Search Within

Roni Shouval

Formats
  1. Meeting Abstract (80)
  2. Journal Article (57)
  3. Review (5)
  4. Editorial (3)
  5. Correspondence (2)
  6. Research Letter (2)
  7. Book Section (1)
  8. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (151)
  2. Center for Hematologic Malignancies (98)
  3. Department of Medicine (98)
  4. Bone Marrow Transplant (92)
  5. CTCR Scholars (78)
  6. Survivorship Research (74)

More Groups

People
  1. Miguel-Angel Perales (89)
  2. Michael Scordo (73)
  3. Gunjan Shah (69)
  4. Maria Palomba (65)
  5. Parastoo Dahi (61)
  6. Sean Devlin (58)

More People

Years
  1. 2025 (12)
  2. 2024 (30)
  3. 2023 (49)
  4. 2022 (23)
  5. 2021 (16)
  6. 2020 (15)

More Years

Publications
  1. Blood (51)
  2. Bone Marrow Transplantation (19)
  3. Blood Advances (14)
  4. Transplantation and Cellular Therapy (11)
  5. Biology of Blood and Marrow Transplantation (6)
  6. Hematological Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (66)
  2. Elsevier Inc. (25)
  3. Nature Publishing Group (24)
  4. Wiley Blackwell (5)
  5. American Association for Cancer Research (4)
  6. Ferrata Storti Foundation (4)

More Publishers

Results (151)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Site-specific responses and extranodal involvement implications in large B-cell lymphomas treated with CD19-CART therapy
    Meeting Abstract

    Luna de Abia, A.; Devlin, S. M.; Flynn, J.; Corona De Lapuerta, M.; Luttwak, E.; Landego, I.; Dahi, P. B.; Lin, R. J.; Parascondola, A.; Palomba, M. L.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Central nervous system bridging radiotherapy (CNS-BRT) achieves rapid cytoreduction prior to car T-cell therapy for aggressive B-cell lymphomas
    Meeting Abstract

    Cederquist, G.; Schefflein, J.; Devlin, S.; Shah, G.; Shouval, R.; Hubbeling, H.; Tringale, K.; Fregonese, B.; Hajj, C.; Boardman, A.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • Improvement in radiomic features following bridging therapy is prognostic for CD19 chimeric antigen receptor (CAR) T-cell therapy outcome
    Meeting Abstract

    Hubbeling, H. G.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G. L.; Fregonese, B.; Bedmutha, A.; Boardman, A.; Dahi, P. B.; more...
    International Journal of Radiation Oncology, Biology, Physics (2024)

    Fulltext@MSK | Save
  • Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Anti-CD19 chimeric antigen receptor T-cell therapy has less efficacy in Richter transformation than in de novo large B-cell lymphoma and transformed low-grade B-cell lymphoma
    Journal Article

    Benjamini, O.; Fried, S.; Shouval, R.; Flynn, J. R.; Beyar-Katz, O.; Leslie, L. A.; Zuckerman, T.; Yerushalmi, R.; Shem-Tov, N.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Metabolic tumor volume response after bridging therapy determines chimeric antigen receptor T-cell outcomes in large B-cell lymphoma
    Journal Article

    Hubbeling, H.; Leithner, D.; Silverman, E. A.; Flynn, J.; Devlin, S.; Shah, G.; Fregonese, B.; Wills, B.; Bedmutha, A.; Alarcon Tomas, A.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Scalable log-ratio lasso regression for enhanced microbial feature selection with FLORAL
    Journal Article

    Fei, T.; Funnell, T.; Waters, N. R.; Raj, S. S.; Baichoo, M.; Sadeghi, K.; Dai, A.; Miltiadous, O.; Shouval, R.; Lv, M.; more...
    Cell Reports Methods (2024)

    Fulltext@MSK | Save
  • CD19-directed CART therapy for T-cell/histiocyte-rich large B-cell lymphoma
    Journal Article

    Pophali, P. A.; Fein, J. A.; Ahn, K. W.; Allbee-Johnson, M.; Ahmed, N.; Awan, F. T.; Farhan, S.; Grover, N. S.; Hilal, T.; Iqbal, M.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Atrial arrhythmias following CAR-chimeric antigen receptor T-cell therapy: Incidence, risk factors and biomarker profile
    Journal Article

    Shouval, R.; Goldman, A.; Flynn, J. R.; El-Moghraby, A.; Rehman, M.; Devlin, S. M.; Corona, M.; Landego, I.; Lin, R. J.; Scordo, M.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Second primary malignancies after CAR T-cell therapy: A systematic review and meta-analysis of 5,517 lymphoma and myeloma patients
    Review

    Tix, T.; Alhomoud, M.; Shouval, R.; Scheffer Cliff, E. R.; Perales, M. A.; Cordas dos Santos, D. M.; Rejeski, K.
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save